Javascript is disabled in your browser. Please enable Javascript to view PeerJ.

March 2021

Table of Contents - PeerJ (Medicine Articles)

March 31, 2021

Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application

Jakub Hynst, Veronika Navrkalova, Karol Pal, Sarka Pospisilova

https://doi.org/10.7717/peerj.10897 PubMed 33850640

March 31, 2021

Comparison of metastatic castration-resistant prostate cancer in bone with other sites: clinical characteristics, molecular features and immune status

Zhengquan Xu, Yanhong Ding, Wei Lu, Ke Zhang, Fei Wang, Guanxiong Ding, Jianqing Wang

https://doi.org/10.7717/peerj.11133 PubMed 33859877

March 30, 2021

COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer

Qishun Geng, Zhibo Shen, Lifeng Li, Jie Zhao

https://doi.org/10.7717/peerj.11145 PubMed 33850663

March 23, 2021

Two predicted models based on ceRNAs and immune cells in lung adenocarcinoma

Miaomiao Zhang, Peiyan Zheng, Yuan Wang, Baoqing Sun

https://doi.org/10.7717/peerj.11029 PubMed 33828913

March 17, 2021

Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma

Prin Sungwan, Worachart Lert-itthiporn, Atit Silsirivanit, Nathakan Klinhom-on, Seiji Okada, Sopit Wongkham, Wunchana Seubwai

https://doi.org/10.7717/peerj.11067 PubMed 33777535

March 5, 2021

Identification of the hub genes in gastric cancer through weighted gene co-expression network analysis

Chunyang Li, Haopeng Yu, Yajing Sun, Xiaoxi Zeng, Wei Zhang

https://doi.org/10.7717/peerj.10682 PubMed 33717664

March 2, 2021

The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study

Qi Zeng, Sha Wang, Jia Tan, Lu Chen, Jinwei Wang

https://doi.org/10.7717/peerj.10830 PubMed 33717678

← Previous
1
Next →